STATE STREET CORP - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2015$23,174,000
-57.5%
3,227,786
+7.1%
0.00%
-50.0%
Q2 2015$54,471,000
+4.7%
3,014,431
-8.9%
0.01%
+20.0%
Q1 2015$52,035,000
+0.1%
3,310,122
-9.9%
0.01%0.0%
Q4 2014$51,966,000
+1.0%
3,672,488
+22.0%
0.01%
-16.7%
Q3 2014$51,434,000
-31.9%
3,009,479
+18.7%
0.01%
-25.0%
Q2 2014$75,522,000
+77.4%
2,535,893
+84.2%
0.01%
+60.0%
Q1 2014$42,583,000
-49.7%
1,376,338
-54.9%
0.01%0.0%
Q4 2013$84,722,000
+56.6%
3,049,003
+130.5%
0.01%
-28.6%
Q3 2013$54,093,000
+12.2%
1,323,003
+5.8%
0.01%
+16.7%
Q2 2013$48,199,0001,250,9140.01%
Other shareholders
THERAVANCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders